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Patient Specific Hardware-in-the-Loop Testing of
Cerebrospinal Fluid Shunt Systems
Manuel Gehlen, Vartan Kurtcuoglu, and Marianne Schmid Daners
Abstract—Goal: The development of increasingly sophisticated
cerebrospinal fluid (CSF) shunts calls for test beds that can
reproduce an ever larger range of physiologic and pathophys-
iologic behaviors. In particular, upcoming smart and active
devices will require extensive testing under complex dynamic
conditions. Herein, we describe a test bed that allows for fast,
cost-effective and realistic in vitro testing of active and passive,
gravitational and non-gravitational CSF shunts based on the
hardware-in-the-loop principle. Methods: The shunt to be tested
is placed in a dynamic in vitro setup that interfaces with a
mathematical model of the patient’s relevant physiology, which
is evaluated numerically in real-time. The model parameters can
be identified using standard clinical tests. The test bed accounts
for posture dependent behavior and viscoelastic effects. Results:
Simulations of infusion tests, of intracranial pressure modulation
by cardiovascular action, and of the effects of postural changes
show good agreement with published results. Evaluation of valves
without and with gravitational units show in modeled sitting
patients the expected behavior of overdrainage and avoidance
thereof, respectively. Finally, a 24-hour test cycle based on
recorded patient data elucidates the interaction between patient
and shunt system expressed by drainage rate and intracranial
pressure during typical daily activities. Conclusion: We envision
this test bed as a tool to quantify a shunt’s performance within
a realistic yet reproducible testing environment. Significance:
The test bed can improve our understanding of the complex
interaction between patient and shunt system and may catalyze
the development of active shunts, while reducing the number of
necessary in vivo experiments.
Index Terms—hardware-in-the-loop, in vitro, testing, hydro-
cephalus, CSF, shunt, posture, animal testing alternatives.
I. INTRODUCTION
IN our current, evolving understanding, “hydrocephalus isan active distension of the ventricular system of the brain
related to inadequate passage of CSF from its point of pro-
duction within the ventricular system to its point of absorption
into the systemic circulation” [1]. While this distension leads
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to elevated intracranial pressure (ICP) and a deformation
of the brain parenchyma in the short term, it can cause a
degeneration of this tissue in the long term. The accompanying
symptoms range from headaches to dementia, gait disturbance,
and urinary incontinence [2]. Hydrocephalus is usually treated
by diverting CSF from the cerebral ventricles through a shunt
into the peritoneal space. Although implantable ventriculoperi-
toneal shunts have been used since the 1960s [3], the overall
failure rate is still high (38% after 1 year and 48% after
2 years [4]). The most common modes of failure are over-
or underdrainage, obstruction, and infection [5], [6].
To prevent siphoning-induced overdrainage in upright pos-
tures, shunt valves can be complemented by gravitational units,
anti-siphon devices, and adjustable mechanisms [3], which
lead to increasingly complex shunt systems. This unsatisfac-
tory situation has led to the vision of an active and smart shunt
that could overcome the drawbacks of current systems through
continuous monitoring of the patient using integrated sensors
and feedback controlled drainage [7].
For the existing passive shunts, a large number of in vitro
studies has already been performed to analyze their fluid
dynamic properties, the effect of ICP pulsations and posture
on these properties, and long-term stability [8]–[14]. In these
studies, the intracranial and peritoneal pressures were assumed
to be independent of CSF drainage. Yet in reality, drainage
does decrease mean ICP, in general also ventricular volume,
and may in addition influence the amplitude of ICP pulsations
[15], [16]. These effects have been demonstrated in other
setups that replicated parts of the patient’s CSF system in vitro
[17]–[21].
For the envisioned active valves, this interdependence of
valve and patient becomes even more pronounced: The shunt
does not only influence the patient, but also adapts to the
measured state of the patient. Up to now, analysis of this
interdependence required in vivo experiments or was per-
formed entirely in silico [22]. The former is closest to the
clinical application, but is expensive, time-consuming, and
raises ethical concerns. For these reasons, in vivo experiments
are hardly used during the early development phases of new
shunts. The latter approach is fast and cost-effective, but
the behavior of the shunt has to be known precisely. Thus,
numerical simulations are a good tool for developing concepts
for new shunts, but in vitro or in vivo testing is still necessary
for the hardware development.
Here we propose to combine an in vitro setup with math-
ematical modeling of the patient’s relevant physiology to a
hybrid test bed. This concept is referred to as hardware-
in-the-loop (HIL) testing. It is commonly used during the
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Fig. 1. Flow chart illustrating the interaction of software (in silico) and hardware (in vitro) parts of the hardware-in-the-loop setup: The basis of each
experiment is a test scenario that determines the angles α1 and α2, venous pressure at the hydrostatic indifference point pV,HIP, and arterial inflow Qarterial.
The set values of α1 and α2 are applied to the shunt by the posture mechanisms as illustrated in Fig. 3. Based on the signals prescribed by the test scenario
and the measured flow rate through the shunt Qmeasshunt, the patient simulation determines the set values for ICP and IPP. ICP and IPP are then applied to the
respective catheter ends by two pressure interfaces also shown in Fig. 2. The input current i for each of the actuators in the hardware-software interfaces is
provided by an amplifier. The set values iset for these amplifiers are determined by controllers, based on the measured signals αmeas1 , α
meas
2 , ICP
meas, and
IPPmeas and their respective references (superscript set).
development of embedded systems [23] and combustion en-
gines [24]. The method has also been applied successfully
in the evaluation of ventricular assist devices [25]. Applied
to the shunt test bed, the HIL concept implies that: 1) the
patient’s relevant physiology is replicated in real-time by a
mathematical model; 2) the relevant simulated pressures for
a ventriculoperitoneal CSF shunt (intracranial pressure (ICP)
and intraperitoneal pressure (IPP)) are applied to the proximal
and the distal ends of the drainage catheter; and 3) the drainage
rate of CSF is measured and fed back to the in silico simulation
in real-time.
In principle, any viable mathematical model of the patients
physiology that yields the two necessary pressure signals
as a function of the continuous measurement of the CSF
drainage rate could be implemented. However, the necessity
to interact with the hardware in real-time currently precludes
complex computational fluid dynamics (CFD) simulations that
can model the CSF dynamics in detail [26]. Thus, lumped
parameter models are best suited. In 1973, Marmarou [27]
published a lumped parameter model of the CSF dynamics
whose parameters are even used to characterize hydrocephalus
[28]. Today, there are a number of ICP models that build
upon the exponential function of this model that describes the
pressure dependence of the compliance and extend it to capture
also other characteristics of the CSF system [29]. While the
model of Marmarou describes the absolute compliance of the
CSF system, which is defined relative to the ambient pressure,
explicit modeling of the membranes between adjacent fluid
compartments led to the concept of local compliances [30].
Some models are even representations of the whole body
and include detailed descriptions of the cardiovascular system
and its regulatory mechanisms [31]. However, most of these
models assume that the patient is in supine position. To predict
ICP of mobile patients, it is necessary to incorporate its posture
dependence [32].
In the following, we describe a HIL test bed and investigate
its suitability for analyzing the interdependence of shunt and
patient dynamics and evaluating the performance of passive
and active shunts during daily life situations including posture
changes. The resulting drainage rates and ICPs are compared
to a reference simulation without shunt and clinical results
reported in literature.
II. METHODS AND MATERIALS
A. General Concept
The test bed consists of an in vitro and an in silico
domain (Fig. 1). Pressure interfaces link these two domains
by applying simulated ICP and IPP to the respective ends of
the catheter. A posture mechanism moves the shunt according
to the current posture of the mimicked patient. The feedback
loop is closed through a flow probe that measures the flow rate
through the shunt and feeds this signal back into the patient
simulation in real-time.
The patient model, all controllers and the data aquisition si-
multaneously run in a Real-Time Windows Target environment
on a Windows 7 PC equipped with two data acquisition boards
(MF634 and MF624 I/O cards, Humusoft s.r.o., Prague, Czech
Republic). The code for the real-time environment is compiled
from MATLAB/Simulink using an implicit fixed-step solver
(ode14x) with a step size of 1 ms. This leads to a sampling
rate of 1 kHz for all analog control and measured signals from
and to the PC, while the drainage rate Qshunt is transmitted
through a digital connection and sampled at 100 Hz.
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Fig. 2. Schematic drawing of the pressure interfaces that apply ICP and IPP
calculated by the patient simulation to the respective ends of the catheter. In
Fig. 1 and Fig. 3, they are identified as ICP and IPP interface, respectively.
The reservoirs are pressurized by a voice coil actuator and feedback controlled
through a ceramic pressure transducer. A distance sensor provides information
on the fluid volume in the CSF reservoir.
B. Hardware-Software Interfaces
1) Intracranial and Intraperitoneal Pressure Interfaces:
The pressures at the proximal and the distal ends of the
catheter are applied through two pressure controlled fluid
reservoirs (Fig. 2), each consisting of a rigid reservoir (poly-
methyl methacrylate) and a bellows (polytetrafluorethylene
bellows, ElringKlinger Kunststofftechnik GmbH, Bietigheim-
Bissingen, Germany) that is compressible in vertical direc-
tion [21]. The pressure in the reservoirs is controlled by
varying the force applied to the bellows. The force is gen-
erated by a linear circular voice coil actuator (LVCM-051-
064-01, MotiCont, Van Nuys, USA), which is powered by
a 4-quadrant servo amplifier (ADS 50/10 4-Q-DC, Maxon
Motor AG, Sachseln, Switzerland), and transferred through
an air bearing (Air Bushing, New Way Air Bearings Inc.)
supported shaft. This low friction actuation allows a resolution
of 0.01 mmHg in the applied reservoir pressure. The reservoir
pressure is measured by a piezo-resistive pressure sensor (PR-
41X, Keller AG, Winterthur, Switzerland) with an accuracy
of 0.1 mmHg and a resolution of 0.01 mmHg. The reservoir
volume is computed from a laser-based measurement of the
bellows position (optoNCDT 1700, Micro-Epsilon, Ortenburg,
Germany). This volume information is used to regulate the
recirculation of the test medium, which enables, in principle,
infinite experiment duration. It further allows verification of
the flow measurement.
2) Posture Mechanism: The patient’s posture is simulated
by moving the shunt and the aforementioned pressure inter-
faces with the mechanism shown in Fig. 3. The mechanism has
two degrees of freedom that replicate rotational movements
TABLE I
CONSTANT PARAMETERS OF TEST BED AND PATIENT MODEL
Name Value Source
Qform 0.35 mL/min [30], [34]–[36]
Rout (physiologic) 8.57 mmHg/(mL/min) [35], [36]
Rout (pathologic) 37.14 mmHg/(mL/min)
EFV = EBV = E
M 0.1 1/mL [21], [35], [36]
p0,FV = p0,BV = pv 7 mmHg [36]
p1,FV = p1,BV = p
M
b 10 mmHg [21], [30], [36]
pV,HIP 7 mmHg [32]
kBV 0.35
kFV = 1− kBV 0.65
RFB 1 mmHg/(mL/min)
∆hHIP 33.8 cm [32]
∆hjug 11.0 cm [32]
l1 47.6 cm [33]
l2 16.5 cm [33]
of the torso (α1) and the head and neck (α2). The beam
lengths l1 and l2 are listed in Table I, where l1 is the
distance between waist and shoulder and l2 between shoulder
and eye height, which is close to the height of the external
auditory canal usually used as the reference position for ICP
measurements. Both values are based on [33] and correspond
to the dimensions of a 50th-percentile 40-year-old American
male. However, these lengths can be easily adapted to specific
patients. The necessary torques to manipulate α1 and α2 are
provided by two DC motors with planetary gearhead and
integrated Encoder (RE 50, G52C 1:113, and HEDS 5540,
Maxon Motors AG). These driving units are powered by 4-
quadrant servo amplifiers (ESCON 50/5, Maxon Motors AG).
3) Flow Probe: The flow through the shunt is measured
using a thermal MEMS sensor (SLI-2000, Sensirion AG,
Staefa, Switzerland) with negligible hydrodynamic resistance
(< 0.05 mmHg). The measurement signal is fed back to the
patient simulation through an RS-232 connection at 100 Hz
sampling rate.
C. Patient Simulation
Fig. 4 outlines the lumped parameter model used in the
following experiments. It is based on a four-compartment
model developed by Stevens and Lakin [30], but modified and
extended to include posture dependence, ICP pulsations, and
visco-elastic effects.
1) Structure: Four fluid filled compartments - denoted F,
B, A, and V - are used to model the patient’s relevant
physiology. Compartment F is the central CSF compartment
that includes the ventricular system, the choroid plexus and the
cranial and spinal subarachnoid space. This implicitly assumes
equal pressure across the fluid spaces that are lumped into
Compartment F. All viscoelastic effects within the craniospinal
space are lumped into Compartment B (mainly brain tissue)
that is connected to the main CSF space (F) through the
constant resistance RFV. The cerebral arteries and the cerebral
and spinal veins are represented by the compartments A and V,
respectively. The dynamics in each of these compartments are
governed by a volume balance of all inflowing and outflowing
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Fig. 3. Overview over the posture mechanism and the integration of the shunt into the system of pressure interfaces, water bath, and incubator. (a) Schematic
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Fig. 4. Lumped parameter model that is used to simulate the relevant ICP
dynamics (Fig. 1), which include the ventricular system and spinal canal (F),
the brain tissue (B), the cerebral arteries (A), and the spinal and cerebral
veins (V). Volume flows are denoted with Qi and arrows indicate their usual
direction. Wavy lines depict compliant vessel walls. Arterial inflow Qarterial,
venous pressure pV , and the drainage rate Qshunt as measured by the flow
probe are inputs to this lumped parameter model. The main output is the CSF
pressure pF in Compartment F that is used as the ICP set value in the ICP
interface.
volume flows Q and an additional algebraic equation that links
the fluid volume V in the compartment to the fluid pressure
p:
d
dt
Vi(t) = −
∑
j
Qij(pi(t), pj(t), t) (1)
Vi(t) =
∑
j
∆Vij(pi(t), pj(t), t), (2)
where t is time, i and j are indices referring to two inter-
connected compartments. The compliance function ∆Vij(·)
describes the amount by which the volume of compartment i
is increased and the one of compartment j is decreased or
vice versa due to the pressure-dependent deformation of the
boundary that separates the two fluid compartments i and
j [30]. In contrast to the commonly used pressure based
description, this volume based representation allows time-
varying compliances and is more intuitive [37]. However, it
turns the system of otherwise ordinary differential equations
into a system of differential algebraic equations that is not
guaranteed to be solvable in real-time.
2) Compliance: The global relationship between ICP and
CSF volume is typically described by Marmarou’s model [27],
[35]:
pMIC = p
M
b e
EM ·∆VM , (3)
which expresses ICP pMIC relative to ambient pressure as an
exponential function of the added CSF volume ∆VM , baseline
pressure pMb , and the brain elastance coefficient E
M (Table I).
The local compliance functions ∆Vij(·) introduced in (2) are
chosen such that for slow volume changes (pF (t) ≈ pB(t))
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- implying equal pressures in Compartments B and F (pB = pF ) - and
for the cerebral venous pressure pV = 7 mmHg with respect to the total
change in CSF volume (∆VFV + ∆VBV). As a reference, the exponential
compliance curve of Marmarou’s model (3) is plotted for baseline pressure
pMb = 10 mmHg and brain elastance coefficient E
M = 0.1 1/mL, which are
typical parameters for a healthy subject [36].
and pF (t) ≥ pV (t) the global pressure-volume relationship
of the patient model is equivalent to the original Marmarou
model (Fig. 5):
∆Vij(t) =
=
{
kij
Eij
· ln pi(t)−pj(t)+p0,ijp1,ij , for pi(t) ≥ pj(t)
kij
Eij
· (2 · ln p0,ijp1,ij − ln
pj(t)−pi(t)+p0,ij
p1,ij
), for pi(t) < pj(t)
(4)
for the parameters listed in Table I. The resulting pressure-
volume relationship is inverted for reversed pressure gradients
(Fig. 5). A similar S-shape of this global pressure-volume
relationship was observed in vivo [38], [39] and it can explain
negative ICP as it occurs following excessive drainage [30],
[40].
3) CSF Formation and Absorption: The overall rate of
CSF formation Qform is assumed constant [34], [35], [41].
While the relative contribution of the different sites of CSF
absorption are still being researched, it appears clear that
the arachnoid granulations are a major pathway; the overall
outflow is thus positive and depends linearly on the hydrostatic
pressure gradient [34], [35]:
Qabs =
{
(pF − pV )/Rout, for pF ≥ pV
0, for pF < pV
(5)
In case of shunting, an additional CSF flow Qshunt is diverted
from compartment F. Qshunt is an input to the mathematical
model and its actual value originates from the flow probe,
which measures the flow rate through the tested shunt in vitro
(Fig. 1).
4) Brain Compartment: From an anatomical point of view,
the compartment B represents the brain tissue and peripheral
parts of the CSF system. It allows for modeling of the vis-
coelastic response that is e.g. observed during bolus infusions
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and the viscoelastic model introduced by Bottan et. al. [36], respectively.
(a) Continuous flow infusion (constant infusion rate of 1.5 mL/min between
t = 0 and 30 min). (b) Bolus infusion (infusion of 10 mL between t = 0 and
0.1 min).
[36]. The effects that may be responsible for this behavior
entail limited wave propagation speeds between distant loca-
tions of the CSF space [42], fluid exchange between CSF and
interstitial fluid [43], and the viscoelastic mechanical response
of the brain tissue [44], [45]. For a simplified model with
constant compliances, it can be shown that with RFB =
1 mmHg/(mL/min) and kBV = 0.35 this lumped compartment
approach is equivalent to the model of Bottan et. al. [36]
(Fig. 6). Their model is an extended version of Marmarou’s
model that uses a Prony series to map the viscoelastic effects
and showed good accordance with measured infusion tests.
5) Cardiovascular System and Posture: While the cardio-
vascular system greatly influences the intracranial dynamics,
the blood flows are hardly altered by the CSF production or
absorption due to the in comparison negligible flow rates.
Therefore, the arterial inflow is a given input to the system
and any theoretical or measured flow function can be applied.
Since pulsations in the intracranial fluid system, which are
introduced through the cardiac action, play an important role
in the distribution of CSF and, more importantly, can alter
the drainage rates through the shunt [12], we use a periodic
pulsating arterial flow function for Qarterial. The values of
this function are based on phase contrast magnetic resonance
imaging of the internal carotid artery in 94 elderly patients
(68±8 years of age) [46].
Compared to the pulsatile flow component of arteries,
pulsatility of capillary vessels is small. The blood flow through
the capillaries Qcap is thus assumed to be non-pulsatile. Its
value is given by the volume balance:
Qcap = Qarterial −Qform (6)
where Qarterial is the mean arterial flow over one cardiac cycle
and Qform is the constant rate of CSF formation. Therefore, the
volume of the blood in compartment A is modeled independent
TBME-01426-2014.R2 - PREPRINT 6
of any pressure. Since the cerebral artery pressure pA is much
higher than the pressures pF and pB in the compartments F
and B at all times, one can assume a constant ratio between
∆VAB and ∆VAF, which then simplifies the patient model to
a system of ordinary differential equations. Further assuming
that the ratio of arterial to venous blood vessels is the same
at the boundaries of the compartments F and B leads to
∆VAB(t)/∆VAF(t) = kBV/kFV. (7)
On the venous side, the system boundary is defined by a
non-pulsatile venous pressure, which depends on the patient’s
posture. This posture dependence is implemented using the
concept of a hydrostatic indifference point in the venous
system and taking collapsible jugular veins into account when
calculating the hydrostatic pressure component of the cerebral
venous pressure pV [32]:
pV =
{
pV,HIP −∆pHIP, for pV,HIP ≥ ∆pHIP −∆pjug
−∆pjug, for pV,HIP < ∆pHIP −∆pjug
(8)
where pV,HIP is the pressure in the hydrostatic indifference
point (HIP) of the venous system, ∆pHIP the hydrostatic
pressure difference in blood between the lateral ventricles
and the HIP, and ∆pjug between the lateral ventricles and
the jugular veins. In the HIL setup, ∆pHIP and ∆pjug are
functions of the angles α1 and α2:
∆pHIP = ρ · g · (l2 · sinα2 + (∆hHIP − l2) · sinα1) (9)
∆pjug = ρ · g ·∆hjug · sinα2 (10)
Due to the concept of local compliances, the posture dependent
cerebral venous pressure pV has an immediate effect on the
pressures in the adjacent compartments pF and pB .
D. Shunt
In principle, any CSF shunt can be tested with the presented
test bed. For the purpose of analyzing and validating the
HIL setup, three identical ball and cone valves (miniNAV,
Christoph Miethke GmbH & Co. KG, Potsdam, Germany)
with 7.4 mmHg (10 cmH20) opening pressure are used. In the
following, the three valves will be denoted as Valve No. 1, 2,
and 3. In one experiment, Valve No. 1 is complemented by
a gravitational unit (proSA, Christoph Miethke GmbH & Co.
KG, Potsdam, Germany) that has 0 mmHg opening pressure
in horizontal orientation and is set to 14.7 mmHg (20 cmH2O)
opening pressure in upright orientation. The valve and, if used,
the gravitational unit are connected to the pressure interfaces
through catheters with 1.2 mm inner diameter. The catheter
lengths from the ICP interface to the valve and from the valve
to the IPP interface are 20 cm and 84 cm, respectively.
E. Test Medium and Ambient Conditions
The test medium, which imitates CSF, is deionized and
deaerated water. The valve and both catheters are submerged
in a water bath filled with the same medium (Fig. 3).
The entire in vitro setup is enclosed within an incubator
kept at 37±1 ◦C, which equals the tissue temperature at the
TABLE II
MODELING OF RELEVANT POSTURES AND DAILY ACTIVITIES
Activity Modeling Source
lying (supine) IPP = 1.8 mmHg, α1 = α2 = 0◦ [47]
sitting IPP = 16.7 mmHg, α1 = α2 = 90◦ [47]
standing IPP = 20.0 mmHg, α1 = α2 = 90◦ [47]
sitting up gradual trunk (α1) and head (α2) movement [49]
lying down reversed sit-up movement
coughing simultaneous increase in IPP and pV,HIP by
up to 68 mmHg and 43 mmHg, respectively
[50]
typical implantation site of the valve and fulfills the require-
ments mandated by the standards BS EN ISO 7197:2009 and
ASTM F647-94(2006). This is done through two feedback
controlled fan heaters (HGL 046 - 400 W, Stego Elektrotechnik
GmbH, Germany). Continuous temperature measurements are
taken using 10 kOhm NTC Thermistors (BetaCurve Inter-
changeable Thermistor, BetaTHERM Sensors, Galway, Ire-
land) at 5 locations: 1) in the ICP reservoir; 2) in the IPP
reservoir; 3) in the water bath next to the valve; 4) in the air
inside the incubator; and 5) in the ambient air outside of the
incubator.
F. Experiments
Initial three sets of experiments were performed to validate
the proposed shunt test bed, to analyze the interaction between
shunt and patient, and to study how this interaction is changed
upon inclusion of a gravitational unit. This was examined in
a synthetic situation where overdrainage would occur in vivo,
as well as during a 24-hour period that resembles a typical
day of a patient.
Experiment 1 (Shunt Characteristic): The shunts’ pressure-
flow characteristics during opening and closing of the valve
were determined by measuring the flow through the shunt
while linearly increasing the pressure difference between the
proximal and the distal ends of the catheter from 0 to 30 mmHg
within 2 mins, and then linearly decreasing it back to 0 mmHg
at the same rate. The experiment was performed twice before
and twice after each of the other experiments: once with the
postural mechanism in horizontal position (α1 = α2 = 0◦)
and once in upright position (α1 = α2 = 90◦). While ICP
changed continuously during this experiment, IPP was kept
constant at 1.8 mmHg and 16.7 mmHg for the experiment
in horizontal and upright position, respectively. These are
realistic IPP values for subjects in supine and sitting position
[47], [48].
Experiment 2 (Synthetic Posture Change): The setup’s abil-
ity to mimic postural changes and posture related overdrainage
was tested by simulating a patient who quickly moves (within
5 s) from supine position to sitting and then goes back to
supine position again (Table II). Each of the three postures was
held for 1 hour to guarantee equilibrium conditions at the end
of each period. The transitions were gradual changes of α1,
α2 and IPP. The initial state of the patient simulation was the
equilibrium state without shunting (pF = pB = 10 mmHg). In
addition to the physiological case with Rout = 8.57 mmHg,
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the experiment was also repeated for a pathological case with
an elevated CSF outflow resistance of 37.14 mmHg, which
corresponds to a patient with an ICP of 20 mmHg in supine
position without shunting. The experiment was repeated three
times for each valve combination. Experiment 2 was also used
to quantify the performance of the pressure interfaces. This
was done by comparing the desired and measured pressures in
the ICP interface, where the ICP pulsations pose high dynamic
requirements for the pressure control.
Experiment 3 (Daily Routine): The idea behind the third
experiment is that for future smart and active shunts it will
not be sufficient to only consider the static characteristic of the
valve, because the valve will adapt to the patient. Therefore,
we need a new means to assess and compare the performance
of these new devices. One promising approach to this problem
is to define a scenario that resembles the daily routine of the
targeted patient or patient group most realistically. This idea
can be compared to the driving cycles that are used to estimate
the fuel consumption and emissions of a given car or truck
within a typical environment [51], [52]. We generated a cycle
from a case study of a subject’s daily routine that was recorded
over 24 hours [50] consisting of the postures and activities
listed in Table II. While this cycle cannot be considered to be
representative, it does serve its purpose of providing a proof of
principle. Valve No. 1 with and without the gravitational unit
was used in connection with the pathologic case for this cycle.
The ICP of a healthy subject (physiologic outflow resistance)
without a shunt was simulated as a benchmark to which the
ICP recorded during the cycle was compared.
III. RESULTS
All recordings of the experiments were filtered with a
second-order zero-phase Butterworth filter with 50 Hz cutoff
frequency using the MATLAB function filtfilt. Results that
are based on multiple measurements are given as mean val-
ues ± standard deviation.
Experiment 1 (Shunt Characteristic)
The pressure-flow characteristics of the tested valves are
depicted in Fig. 7, and their measured opening pressures are
listed in Table III. The valve manufacturer defines the opening
pressure as the pressure necessary to obtain a drainage rate
of 0.083 mL/min (5 mL/h). According to this definition, the
measured opening pressure over the valve, both catheters and
the flow sensor is 7.17± 1.02 mmHg (measurements on the
three separate ball and cone valves of the same type). The
nominal opening pressure for the valves without catheters
is 7.4 mmHg (10 cmH2O). Adding the gravitational unit to
one of the ball and cone valves (Valve No. 1) does not
change the measured opening pressure of this valve in supine
position notably. It does, however, increase flow resistance
above the opening pressure (Fig. 7b) and it increases the
opening pressure in upright position to 16.98± 1.05 mmHg
(Table III).
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Fig. 7. Experiment 1: Pressure-flow characteristics during opening and closing
of the tested valves. The curves represent mean values over four repetitions of
Experiment 1 in horizontal position and four repetitions in upright position.
Error bars indicate the standard deviations at 5, 10, 15, 20, and 25 mmHg. (a)
Ball and cone valves No. 1-3. (b) Valve No. 1 combined with the gravitational
unit (GU) with separate curves for horizontal and upright position.
Experiment 2 (Synthetic Posture Change)
Experiment 2 shows how the drainage rate and ICP evolves
when a patient sits up or lies down, and how this behavior
is affected by the addition of a gravitational unit to the ball
and cone valve. As an example, Fig. 8 shows the ICP and
flow rate through the shunt for one iteration of the experiment
and compares the measurements to reference values obtained
by simulation without shunt. In this reference case, mean
ICP is 10.00 mmHg in supine position. In sitting position,
the proximal catheter tip rises above the CSF system’s point
of hydrostatic indifference. This posture-induced reduction in
the hydrostatic pressure at the ICP reference point leads to
negative mean ICP (−5.10 mmHg) relative to ambient pressure
[32]. The corresponding movements of the posture mechanism
are visualized in a video clip accompanying this manuscript.
We use the equilibrium conditions in supine and sitting posture
and the time it takes to reach these to quantify the experimental
results. The equilibrium values are averaged over the periods
20 min < t < 60 min and 80 min < t < 120 min for supine
and sitting position, respectively. In the following, we consider
equilibrium to have reached when the mean ICP is and stays
within 1 mmHg of this value.
1) Physiological Case: For the physiological case with
Rout = 8.57 mmHg/(mL/min) and supine position, the
shunt decreases ICP from 10 mmHg (reference case, no
shunt) to 9.10± 0.38 mmHg. After sitting up, ICP in-
stantaneously falls to −6.24± 0.36 mmHg due to the in-
creased hydrostatic pressure difference. However, this fall in
ICP and the modeled increase in IPP (from 1.8 mmHg to
16.7 mmHg) does not fully compensate the hydrostatic water
column in the catheter, which leads to a maximum drainage
rate of 4.41± 0.20 mL/min (averaged over one cardiac cy-
cle). Equilibrium is reached after 9.21± 1.49 min at ICP
of −21.06± 1.34 mmHg. The patient’s recovery from this
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TABLE III
MEAN VALUES AND PEAK-TO-PEAK AMPLITUDES OF ICP AND SHUNT FLOW AFTER STEADY STATE WAS REACHED DURING EXPERIMENT 2.
ICP (mmHg) Shunt Flow (mL/min)
Posture Valve Opening Pressure (mmHg) mean amplitude mean amplitude
Supine no shunt 10.00 1.14 0.00 0.00
No. 1 8.34± 0.32 9.60± 0.08 1.09± 0.01 0.05± 0.01 0.04± 0.01
No. 2 6.65± 0.39 8.82± 0.08 1.01± 0.01 0.14± 0.01 0.06± 0.02
No. 3 6.47± 0.11 8.89± 0.02 1.01± 0.00 0.13± 0.00 0.06± 0.01
No. 1 + grav. unit 8.54± 0.80 9.69± 0.04 1.10± 0.00 0.03± 0.00 0.02± 0.00
No. 1 (increased Rout) 8.29± 0.46 11.61± 0.48 1.32± 0.05 0.22± 0.01 0.13± 0.01
Sitting no shunt −5.10 1.14 0.00 0.00
No. 1 8.62± 0.64 −19.36± 0.33 2.14± 0.04 0.35± 0.01 0.35± 0.01
No. 2 6.52± 0.62 −21.68± 0.62 2.41± 0.07 0.34± 0.01 0.38± 0.03
No. 3 6.44± 0.10 −22.15± 0.03 2.47± 0.00 0.35± 0.00 0.39± 0.01
No. 1 + grav. unit 16.98± 1.05 −9.07± 0.06 0.94± 0.01 0.35± 0.02 0.04± 0.00
No. 1 (increased Rout) 8.12± 0.30 −20.25± 0.51 2.24± 0.06 0.35± 0.00 0.30± 0.06
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Fig. 8. Experiment 2: Simulation of a patient with physiological outflow resistance of Rout = 8.57 mmHg/(mL/min) and an implanted ball and cone valve
(Valve No. 2). The patient sits up from supine position at t = 60 min and lies back down at t = 120 min. As a reference, the experiment is plotted for the
same patient without shunt. The signals are plotted with 0.1 s sampling time, thus the line widths are proportional to the amplitude of the signal pulsations.
Two zoomed segments of this plot, which give detailed views of the effect of vasculature pulsation, are shown in Fig. 9.
overdrainage is slower and takes 34.68± 1.12 min.
A metric that gives an indication of the patient’s current
compliance is the amplitude of the ICP pulsations. In the
reference case, the peak-to-peak amplitude is 1.14 mmHg
independent of the patient’s posture. With the shunt, this
decreases slightly to 1.04± 0.04 mmHg for the supine position
and increases to 2.34± 0.16 mmHg while sitting.
2) Pathological Case: When conducting the same experi-
ment, but with increased outflow resistance, ICP is only de-
creased to 11.61± 0.48 mmHg in supine position while divert-
ing 0.22± 0.01 mL/min through the shunt. The overdrainage
in the sitting posture (0.35± 0.00 mL/min) still leads to an
equilibrium ICP of −20.25± 0.51 mmHg. As expected, the
difference to the physiological case is small here, because
the resulting ICP is below the cerebral venous pressure pV
(−8.10 mmHg in sitting posture). Therefore, the entire CSF
production (0.35 mL/min) is diverted through the shunt in both
cases.
3) Gravitational Valve: Adding a gravitational unit to the
valve does not change the equilibrium ICP in the supine
position notably (9.69± 0.04 mmHg). During the sitting phase
of the experiment, all of the CSF produced is still drained
through the shunt. The ICP, however, is only lowered to
−9.07± 0.06 mmHg, which also keeps the ICP pulsations
(0.94± 0.01 mmHg) closer to the reference scenario.
4) Pressure Control: For Experiment 2, Fig. 9 compares
within a time window of three seconds the pulsatile ICP values
prescribed by the in silico domain with the ICP measured in
the reservoir of the ICP interface. The mean absolute error
(MAE) in the interface is 0.075 mmHg over all experiments.
The maximum absolute error stays below 1 mmHg in all ex-
periments. After compensating for the delay of 25 ms between
the in silico and the in vitro domains, the MAE decreases to
0.007 mmHg. For the IPP interface, the MAE is 0.027 mmHg.
Compensating for the delay does not significantly change the
error here, because the reference signal for this compartment
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Fig. 9. Comparison between set (by the in silico domain) and measured (in
the in vitro domain) ICP values in Experiment 2 presented in Fig. 8. The
bottom panels show the corresponding measured pulsatile drainage rate. (a)
Supine position: Time window starts at t1 = 40 min into the experiment. (b)
Sitting: Time window starts at t2 = 100 min.
is not pulsatile.
Experiment 3 (Daily Routine)
Fig. 10 depicts the results of Experiment 3 carried out
with valve No. 1, without the gravitational unit. At nighttime,
the simulated patient is in supine position, and the ICP
stabilizes around the equilibrium ICP in supine position that
was determined in the synthetic posture change experiment. At
daytime, the patient is mainly sitting or standing. There are
numerous transitions between these postures. Therefore, the
simulated IPP alternates between 16.7 mmHg and 20 mmHg,
while the vertical distance between the proximal and the
distal end of the catheter remains constant. In the reference
simulation, which mimics a healthy subject without shunt,
the mean ICP is −5.10 mmHg in sitting or standing position.
The behavior of the shunted patient is different in two ways:
First, overdrainage occurs and low ICP values as measured
in Experiment 2 can be observed. Second, CSF drainage rate
and with it ICP are directly dependent on IPP. This means
that the ICP in standing position is higher than in sitting
position. Adding a gravitational unit hardly influences ICP at
nighttime, but reduces overdrainage while the patient is sitting
or standing. The pressure spikes in Fig. 10 are the result of
coughing, which is modeled as outlined in Table II. These
pressure peaks result in mainly negative spikes in the measured
flow rate, which will cause the valve to close. However, they
do not have any significant and prolonged effect on the ICP.
Over the entire 24-hours cycle, the mean absolute difference in
ICP between shunted patient and healthy subject is 9.16 mmHg
without gravitational unit and 2.29 mmHg with.
IV. DISCUSSION
The results presented at hand demonstrate that the HIL test
bed can be used to study the static and dynamic properties of
CSF shunts, and their interaction with the patient.
The opening pressures and characteristics obtained in Exper-
iment 1 compare well with the manufacturer’s specifications,
but also show marked differences between the measured mean
opening pressures of valve No. 1 and the remaining two valves,
which are larger than the experiments’ standard deviations.
In Experiment 2, we were able to reproduce the problem
of overdrainage when using a standard differential pressure
valve, and observe how the addition of a gravitational unit can
prevent it. The high measured flow rates and the subsequent
fall in ICP are in good agreement with the literature [8].
In the same experiment, we observed that in supine position
the valves start continuously draining before the difference
between mean ICP and IPP rises above the valve’s opening
pressure (Fig. 9). While it is known that the apparent opening
pressure is lowered in the presence of pressure pulsations [12],
it was assumed that CSF is only drained during the pressure
peaks. The continuous flow in our experiment might be due
to a hysteresis in the valve opening. This result highlights that
the drainage is influenced by ICP pulsations; these should thus
be taken into account when testing CSF shunts.
We know from in vivo studies that the amplitude of ICP
pulsations increases with elevated mean ICP and can be
decreased through shunting until a certain minimum amplitude
[53], [54]. In supine position, we can reproduce the reduction
in ICP pulse amplitude with all shunts. In sitting position,
however, the amplitude is only decreased with the gravitational
unit. For the very low ICP values that are reached during
overdrainage, we measure even higher amplitudes than without
shunting, which is due to the symmetry of the compliance
curve around the venous pressure (Fig. 5). A similar amplitude
increase at negative ICP has been observed after withdrawal
of CSF in dogs [40], [55].
Experiment 2 further proves that the feedback controllers
of the critical pressure interfaces are able to follow the
respective reference curves precisely. The interfaces can apply
any pathophysiologic pulse waveform or pressure spike to the
shunt. The delay that is introduced by the controlling feedback
loop is small. It is even irrelevant when looking at periodically
pulsating signals.
The cycle simulated in Experiment 3 is only based on the
recordings of one subject, and should thus not be considered
representative of any subpopulation of hydrocephalus patients.
The experiment does, however, demonstrate the feasibility
of simulating an arbitrary daily routine for a period of
24 hours or longer. By comparing the simulated ICPs of such
an experiment to a reference simulation, we can provide a
simple metric that quantifies the performance of CSF shunts
for a realistic scenario. The two results of the shunt with
and without the gravitational unit suggest that the metric is
sensitive to improvements in shunt technology. In contrast to
measurements of the shunt’s pressure-flow characteristic, the
results will even be meaningful for active shunts that adapt
to the posture of the patient, mean ICP or the ICP pulse
waveform.
Compared to pure in vitro implementations, the main advan-
tages of the HIL approach used for our setup are the flexibility
of the patient model and its determinism: The simulated patient
or the severity of the pathology can be changed by adjusting
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Fig. 10. Experiment 3: Simulation of a shunted patient’s routine activities over a 24-hour period. The patient has increased outflow resistance. No gravitational
unit is implanted. As a reference, the same activities of a healthy, not shunted subject with physiological outflow resistance are simulated. The signals are
plotted with 0.1 s sampling time, thus the line widths are proportional to the amplitude of the signal pulsations.
the model parameters. Sets of parameters representing specific
patients or patient groups can at least in part be derived from
available clinical data such as ICP recordings during lumbar
infusions tests. Physiologic and pathophysiologic increases
in abdominal pressure as they occur, respectively, during
pregnancy and due to obesity can be taken into account by
increasing mean IPP. Finally, HIL testing can be extended to
ventriculoatrial and ventriculopleural shunts by adapting the
posture mechanism and patient model.
V. CONCLUSION
Our test bed can be used to quantify and assess the expected
performance of passive and active shunts in a realistic environ-
ment. The HIL approach on which the test bed is based does
not only provide a means of comparison for existing shunts;
it can also stimulate the development of smart and active
shunts by lowering the burden of implementing and testing
new concepts and ideas. In combination with comprehensive
and well specified test cycles, we can imagine the application
of HIL testing during the regulatory approval process of new
devices.
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